StockData
Kiniksa Pharmaceuticals International, plc logo

Kiniksa Pharmaceuticals International, plc (KNSA) stock

KNSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 14/30469% above fair value
$95.11+0.88 (+0.93%)

Close on Nov 17, 2026Market cap $14.95BP/E 73.2Yield –

Kiniksa Pharmaceuticals International EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Kiniksa Pharmaceuticals International's EV/EBITDA was 71.7× on Nov 11, 2026, against 73.3× a year earlier. Over the last 2 years it ranged from 22.1× to 432.7×, with a median of 49.4×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202671.7×+0.9
2025Dec 31, 202570.8×+48.7
2023Oct 31, 202322.1×–

More Kiniksa Pharmaceuticals International figures

See a number that looks wrong?